| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/07/2011 | US7956047 Stimulating formation of collagen based extracellular matrix; fibrillogenesis agonism; wound healing |
| 06/07/2011 | US7956046 Cardiovascular disorders eg venous thrombosis, arterial thrombosis, deep vein thrombosis, pulmonary embolism, unstable angina, myocardial infarction, cardiac ischemia, occlusive diseases of the peripheral arteries and atrial fibrillation, smooth muscle cell proliferation, atherosclerosis, arteriosclerosi |
| 06/07/2011 | US7956045 Improving the health of ruminant animals, increasing milk production in lactating animals, and/or treating and controlling infective diarrhea by the oral administration of an effective amount of an indigestible oligosaccharide of gluco-oligosaccharides and/or isomalto-oligosaccharides; feed additives |
| 06/07/2011 | US7956044 Compositions comprising inhibitors of RNA binding proteins and methods of producing and using same |
| 06/07/2011 | US7956043 oligonucleotides having a '5TCG motif without any additional unmethylated CpG motifs have strong immunostimulatory capability |
| 06/07/2011 | US7956042 Crystalline forms of macrolide compounds endowed with antiinflammatory activity |
| 06/07/2011 | US7956041 Prophylactic and therapeutic agent of diabetes mellitus |
| 06/07/2011 | US7956040 Combination of catechin and quercetin for pharmaceutical or dietary use |
| 06/07/2011 | US7956039 Use of amygdalin analogues for the treatment of psoriasis |
| 06/07/2011 | US7956036 Polypeptide and DNA thereof useful as a neovascular marker |
| 06/07/2011 | US7956030 Method for reducing pain with ziconotide and baclofen |
| 06/07/2011 | US7956009 Fungicidal combinations of active substances |
| 06/07/2011 | US7955997 Electrostatically charged filter media incorporating an active agent |
| 06/07/2011 | US7955844 Multimodality imaging of reporter gene expression using a novel fusion vector in living cells and animals |
| 06/07/2011 | US7955626 Method for enhancing the DNA repair process, treating disorders associated with the DNA repair process, enhancing antitumor response and treating disorders associated with anti-tumor response in mammals by administering purified quinic acid and/or carboxy alkyl ester |
| 06/07/2011 | US7955624 Compositions and methods for increasing adipose metabolism, lipolysis or lipolytic metabolism via thermogenesis |
| 06/07/2011 | US7955621 Pharmaceutical formulation comprising levothyroxine sodium |
| 06/07/2011 | US7955619 Abuse resistant drugs, method of use and method of making |
| 06/07/2011 | US7955618 Composition for treatment of inflammatory disorders |
| 06/07/2011 | US7955614 Microfabricated nanopore device for sustained release of therapeutic agent |
| 06/07/2011 | US7955607 Method of evaluating evenness of suplatast tosilate crystal, even crystal, and process for producing the same |
| 06/07/2011 | US7955594 Polymers with structure-defined functions |
| 06/07/2011 | US7955356 Laterally insertable interspinous process implant |
| 06/07/2011 | US7954190 Process for increasing liquid extraction from fabrics |
| 06/07/2011 | CA2785233A1 .beta.-carbolines for treatment of hearing damages and vertigo |
| 06/07/2011 | CA2685579A1 Prostate perform |
| 06/07/2011 | CA2647932C Agent for the prevention and treatment of prostatic hyperplasia comprising pyrazolopyrimidinone compound |
| 06/07/2011 | CA2637215C Oral dtpa for radionuclide chelation |
| 06/07/2011 | CA2628607C Androgen synthesis inhibitors |
| 06/07/2011 | CA2613155C Substituted cyclobutane,its preparation process and its medical use |
| 06/07/2011 | CA2596756C Diaminophenothiazine compositions and uses thereof |
| 06/07/2011 | CA2581025C Polymorphic and amorphous forms of the phosphate salt of 8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6h-azepino[5,4,3-cd]indol-6-one |
| 06/07/2011 | CA2574721C Ngna compositions and methods of use |
| 06/07/2011 | CA2567306C Radiosensitizer |
| 06/07/2011 | CA2555824C Fused-ring 4-oxopyrimidine derivative |
| 06/07/2011 | CA2551141C Derivatives of n-(1,5-diphenyl-1h-pyrazol-3-yl) sulphonamide with cb1 receptor affinity |
| 06/07/2011 | CA2531646C Dry powder for inhalation comprising a formoterol salt and ciclesonide |
| 06/07/2011 | CA2523117C Methods of performing medical procedures which promote bone growth, compositions which promote bone growth, and methods of making such compositions |
| 06/07/2011 | CA2521732C Substituted 3-cyanothiophene acetamides as glucagon receptor antagonists |
| 06/07/2011 | CA2520919C Improved penetration of active substances into cells and organs |
| 06/07/2011 | CA2506157C Treatment of diabetes |
| 06/07/2011 | CA2505545C Indolyl derivatives |
| 06/07/2011 | CA2490573C Improved transdermal delivery system |
| 06/07/2011 | CA2484816C Halo-alkyl esters of camptothecins and methods of treating cancer using these compounds |
| 06/07/2011 | CA2483164C Pyrrolo-triazine aniline compounds useful as kinase inhibitors |
| 06/07/2011 | CA2482004C Compounds having unique cb1 receptor binding selectivity and methods for their production and use |
| 06/07/2011 | CA2480026C Ester derivatives of a decahydroisoquinoline-3-carboxylic acid as analgesics |
| 06/07/2011 | CA2473068C Starch derivatives, starch active-substance conjugates, method for their preparation and their use as drugs |
| 06/07/2011 | CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate |
| 06/07/2011 | CA2470515C Dna minor groove binding compounds |
| 06/07/2011 | CA2466580C Orodispersible tablets containing fexofenadine |
| 06/07/2011 | CA2456977C Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 06/07/2011 | CA2455774C Sugar derivatives of hydromorphone, dihydromorphine and dihydroisomorphine, compositions thereof and uses for treating or preventing pain |
| 06/07/2011 | CA2444634C Spiropyrazole compounds |
| 06/07/2011 | CA2444046C Use of colesevelam in reducing serum glucose |
| 06/07/2011 | CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours |
| 06/07/2011 | CA2435685C Desaturase genes and uses thereof |
| 06/07/2011 | CA2423868C Carbamic acid compounds comprising an amide linkage as hdac inhibitors |
| 06/07/2011 | CA2418422C Novel kallikrein gene |
| 06/07/2011 | CA2405705C The treatment of respiratory diseases |
| 06/07/2011 | CA2404431C Guanylyl cyclase c in the detection of stomach and esophageal cancers |
| 06/07/2011 | CA2388857C Contraceptive medicament based on a progesterone and an oestrogen and method for producing the same |
| 06/07/2011 | CA2386515C Piperazine derivatives |
| 06/07/2011 | CA2377627C Cartilage enhancing food supplements and methods of preparing the same |
| 06/07/2011 | CA2361496C Ph independent extended release pharmaceutical formulation |
| 06/07/2011 | CA2349838C Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same |
| 06/07/2011 | CA2306216C The use of inhibitors of the renin-angiotensin system for the treatment of cachexia and wasting |
| 06/07/2011 | CA2298823C Stabilized composition comprising a benzimidazole type compound |
| 06/07/2011 | CA2230556C Novel procollagens |
| 06/07/2011 | CA2213759C Method for treating amyloidosis |
| 06/06/2011 | WO2010068580A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 06/06/2011 | CA2745882A1 Novel crystalline forms of an inhibitor of 11-beta-hydroxysteroid dehydrogenase type 1 |
| 06/03/2011 | WO2011066582A1 Anticancer compounds and screening method |
| 06/03/2011 | WO2011066578A1 Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules to treat liver cancer |
| 06/03/2011 | WO2011066545A1 Treatment of human osteosarcoma |
| 06/03/2011 | WO2011066544A2 Deuterated compounds useful for treating neurodegenerative diseases |
| 06/03/2011 | WO2011066542A2 6-substituted estradiol derivatives and methods of use |
| 06/03/2011 | WO2011066537A1 Nitroxide therapy for the treatment of von hippel - lindau disease (vhl) and renal clear cell carcinoma (rcc) |
| 06/03/2011 | WO2011066506A1 2-METHYLENE-19,26-NOR-(20S)-1α-HYDROXYVITAMIN D3 |
| 06/03/2011 | WO2011066484A2 Isoxazoline compounds in type 2 diabetes and other maladies |
| 06/03/2011 | WO2011066475A1 Sirna compounds comprising terminal substitutions |
| 06/03/2011 | WO2011066418A1 The tumor-selective anti-cancer prodrug bqc-g |
| 06/03/2011 | WO2011066417A2 Antibodies and conjugates for modulators of angiogenesis |
| 06/03/2011 | WO2011066416A1 Compounds, compositions and methods for treatment of protozoan infections |
| 06/03/2011 | WO2011066414A1 Arachidonic acid analogs and methods for analgesic treatment using same |
| 06/03/2011 | WO2011066379A2 METHOD OF REDUCING INTRATUMORAL pHe AND ACID-MEDIATED INVASION |
| 06/03/2011 | WO2011066352A1 An amorphous and a crystalline form of genz 112638 hemitartrat as inhibitor of glucosylceramide synthase |
| 06/03/2011 | WO2011066263A1 Transcription factor inhibitors and related compositions, formulations and methods |
| 06/03/2011 | WO2011066260A2 Formulations comprising aminosterols |
| 06/03/2011 | WO2011066211A1 Azabenzimidazoles as fatty acid synthase inhibitors |
| 06/03/2011 | WO2011066201A2 Methods and systems for treating and preventing cardiac injury in dystrophic subjects |
| 06/03/2011 | WO2011066184A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | WO2011066183A1 Novel spiropiperidine compounds |
| 06/03/2011 | WO2011066182A2 Socs3 inhibition promotes cns neuron regeneration |
| 06/03/2011 | WO2011066179A1 Novel compounds as receptor modulators with therapeutic utility |
| 06/03/2011 | WO2011066176A1 Process for preparing a polymorph of the choline salt of a pyrimidin-5-yl acetic acid derivative |
| 06/03/2011 | WO2011066168A1 Potassium channel modulators |
| 06/03/2011 | WO2011066147A2 Novel salt forms of pyrimidin-5-yl acetic acid derivative |
| 06/03/2011 | WO2011066107A1 Inhaled fosfomycin/tobramycin for the treatment of chronic obstructive pulmonary disease |
| 06/03/2011 | WO2011066082A2 Markers associated with ribavirin-induced anemia |